Description: India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats.
Home Page: www.igcinc.us
IGC Technical Analysis
10224 Falls Road
Potomac,
MD
20854
United States
Phone:
301 983 0998
Officers
| Name | Title |
|---|---|
| Mr. Ram Mukunda | Pres, CEO & Director |
| Ms. Claudia Grimaldi | VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director |
| Mr. Rohit Goel | Sr. Director of Accounting & Principal Accounting Officer |
| Mrs. Parveen Mukunda | Corp. Sec. |
| Dr. Ranga C. Krishna M.D. | Sr. Advisor |
Exchange: NYSE MKT
Country: US
Currency: US Dollar ($)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Capital Goods |
| GIC Industry: | Trading Companies & Distributors |
| GIC Sub-Industry: |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0632 |
| Price-to-Sales TTM: | 29.735 |
| IPO Date: | 2006-04-13 |
| Fiscal Year End: | March |
| Full Time Employees: | 52 |